A CLEARER PICTURE; New Imaging Technologies Are Helping Doctors Target Lesions on the Prostate That Can Harbor Cancer, Bringing to Treatment of the Reproductive Gland a Tool Long Used to Fight Cancer in Other Parts of the Body. [Derived Headline]...
Lesions may be present only focally on prostatic biopsies, and care must be taken to detect these lesions when evaluating prostate biopsies for other processes. There appears to be no correlation between the pattern of STUMP and association with stromal sarcoma. Approximately half of all reported ...
OBJECTIVE: Increased FDG uptake in the prostate can be caused by both benign and malignant conditions. The purpose of this pictorial review is to demonstrate a spectrum of prostate lesions which can show increased FDG uptake on PET/CT imaging. CONCLUSION: Various prostate lesions can show ...
Dr Singer on Choosing Between Frontline IO/IO and IO/TKI Regimens in RCC Dr McGregor on Future Biomarker Analyses With Nivolumab Plus Ipilimumab in Bladder Cancer Dr Berchuck on Next Steps for Evaluating a Novel Liquid Biopsy for PSMA in mCRPCRelated Content View More Prostate CancerImmuno-Oncol...
This chapter deals primarily with a variety of nonneoplastic and neoplastic lesions that are characterized by müllerian differentiation on histologic examination but a distribution that is predominantly external to structures derived from the miillerian ducts. These lesions typically occur in the pelvis an...
The Prostate Imaging Reporting and Data System(PI-RADS)has good ability to identify the nature of lesions on prostate magnetic resonance imaging(MRI).However,some lesions are still reported as PI-RADS 4 and 5 but are biopsy-proven benign.Herein,we aimed to summarize the reasons for the negativ...
Re: Risk Stratification of Equivocal Lesions on Multiparametric Magnetic Resonance Imaging of the Prostate : T. Ullrich, M. Quentin, C. Arsov, A. K. Schmaltz, A. Tschischka, N. Laqua, A. Hiester, D.Blondin, R. Rabenalt, P. Albers, G. Antoch and L. Schimm枚ller J Urol 2018;...
The HOXB13 gene is a member of the homeobox gene family, and prostate development depends on HOXB13 function. HOXB13 is a very sensitive and specific marker of prostate tissue and prostate cancer. When the origin of a tumor in a resection specimen or in biopsy material is unclear, it al...
In a systematic prostate biopsy, 10 to 12 transrectal ultrasound (TRUS)-guided tissue samples are obtained: one each on both sides of the prostate in the base, midgland and apex, and four to six lateral samples covering the peripheral zone [15,16,17]. It has been shown that obtaining mo...
uncertainty has led in Europe to the categorization of benign papillary lesions in biopsies as lesions of uncertain malignant potential or B3 on a 5 scale, regardless of the presence of cellular atypia [69]. In addition, the diagnosis of atypical epithelial proliferations on a biopsy may be ...